ONCODEcipher Colon & Endometrial Premium NGS Panel
Product Description:
FFPE DNA & blood panel targeting 67 relevant genetic mutations in colon and endometrial cancer AND microsatellite instability (MSI) status to provide treatment options & prognostic indications.
Highlighted Genes -- Mutations of RAS/ RAF/ MEK/ MAP kinase signaling pathway, NR-21, NR-24, BAT-25, BAT-26, MONO-27 and etc.
Technique:
Next Generation Sequencing (NGS)
Test Methodology:
Cell free DNA extracted from plasma is subjected to amplification-based library preparation and massively parallel sequencing. Sequencing analysis is performed using commercial bioinformatics pipelines and annotation is done using proprietary and public databases.
Specimen Requirements:
- 3ml Blood in 1 EDTA tubes
- FFPE Block or 10-15 Unstained Slides
- 1 H&E Stained Slide
- HPE report
Turn Around Time:
15 working days
Shipment Requirement:
Keep specimens at room temperature. DO NOT ship on ice or dry ice or expose to direct sunlight.